Methyl 3-{[(tert-butoxy)carbonyl]amino}-2-hydroxypropanoate, 95+%, 1g

6-Ethyl-2-hydrazino-1,3-benzothiazole, 95.0%, 250mg

2-Methyl-2,4-pentanediol, min 99%, pour synthèse, 1L, emballage plastique.

Droxidopa, 95+%, 250mg

Balance de précision série EHA, 0,1 g, 500 g, EHA 500-1

6-Methyl-1H-indazole-7-boronic acid pinacol ester, 98+%, 250mg

2-(4-Methoxy-3-propoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

3-Bromo-2,4-dimethoxypyridine, 97%, 1g

Monochlorhydrate de L-ornithine, min.99%, pour la biochimie, 500 g, emballage plastique.

N,N-DIETHYL-5-METHYL-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-AMINE, 95.0%, 50mg

3,6-Dimethoxypyridazine, 97.0%, 100g

3-(4-chlorophenyl)-5-(piperidin-4-yl)-1,2,4-oxadiazole, 95.0%, 250mg

1-Butanone, 1-(10H-phenothiazin-10-yl)-2-(5H-1,2,4-triazino[5,6-b]indol-3-ylthio)-, 98%, 10mg